Dr. Robert Turner, General ManagerIts microbiology division provides sterility, bioburden, endotoxin and microbial identification testing that complies with USP and Ph. Eur. standards. These capabilities ensure the microbiological integrity of every stage of product development.
“The two biggest things that we value are quality and patient safety. That for us comes above all else we do,” says Dr. Rob Turner, General Manager of Wickham Micro.
A One-Stop Global Testing Partner
Cormica’s network of accredited laboratories operates under the oversight of the MHRA, FDA and UKAS. Client audits occur every week of the year, ensuring processes remain fully compliant and transparent.
This constant scrutiny has built a reputation for reliability. With laboratories in the UK, the United States and Europe, Cormica offers clients a single testing ecosystem that covers analytical, physical and microbiological disciplines maintaining turnaround speed and consistency. The recent acquisition of Zwisler Laboratorium GmbH in Germany expanded European coverage and improved cross-border capacity balancing.
Working across multiple regions means managing different documentation and validation requirements, including the added post-Brexit complexity of separate regulatory frameworks. Cormica helps clients navigate these challenges through collaborative validation planning and compliance mapping. The goal is to prevent costly remediation and ensure timely market release.
-
The two biggest things that we value are quality and patient safety. That for us comes above all else that we do.
Cormica’s teams stay ahead of changing expectations, most notably, by attending regulatory conferences and contributing to discussions that shape industry standards.
Dr. Turner cites the company’s leadership in implementing new Good Regulatory Practice characterisation protocols before they became formal requirements. “We identified this shift early by reviewing guidance documents and attending MHRA events. The inspector later complimented us for being an industry setter of these practices”
Investment in People and Digital Systems
Subject Matter Expert programs keep staff aligned with evolving MHRA, FDA and EMA regulations. Continuous professional development, supported by attendance at exhibitions and technical forums, ensures that knowledge gained in one project strengthens the next.
Cormica is also completing a lean digital management system rollout to improve visibility and client communication. The platform is being validated to meet global data integrity standards and enhance operational efficiency.
The company’s expertise extends across multiple sectors. During the pandemic, Cormica validated sterilisation for ventilators under accelerated timelines. Its teams have also tested surgical packs for hospitals, verifying sterilisation methods for complex multi-component kits, and assessed air quality systems for major infrastructure projects. Even outside healthcare, Cormica has validated the cleanliness of polymer banknotes, applying the exact precision required in regulated life-science environments.
Beyond compendial testing, the company’s laboratories design infection models, develop cleaning verification programs and evaluate air filtration systems for cleanrooms and containment facilities. These projects highlight Cormica’s adaptability and problem-solving depth when requirements go beyond standard methods.
Consistency, Trust and Measurable Quality
Many Cormica leaders, including Dr. Turner himself, once worked as clients. “They were always the go-to people because you knew exactly what you were getting,” he recalls.
Today, that consistency defines the Cormica group. Through accredited science, digital innovation and a culture of continuous improvement, the company continues to help life-science manufacturers confidently meet Current and future testing and regulatory challenges.
Microbiological Testing Service Info
Why is Cormica recognized among Top Microbiological Testing Services providers?
Cormica is recognized among Top Microbiological Testing Services providers due to its long-standing expertise in pharmaceutical and medical device microbiology. Its Microbiological Testing Services cover sterility testing, bioburden analysis, endotoxin detection and microbial identification across global laboratories in the UK, EU and US. With regulatory audits from agencies such as the FDA and MHRA, it delivers validated, defensible data that supports safe product release and regulatory approval.
What makes Cormica’s Microbiological Testing Services different from standard laboratory testing providers?
Cormica differentiates its Microbiological Testing Services through its integrated, full-lifecycle testing approach. Instead of isolated lab work, it connects microbiology with analytical chemistry, physical testing and regulatory consulting under one framework. This allows manufacturers to manage development, validation, and product release through a single testing partner. Its ability to operate across multiple regulated regions also ensures consistent microbiological standards globally.
How does Cormica support pharmaceutical manufacturers through Microbiological Testing Services?
Cormica supports pharmaceutical companies by delivering structured microbiological testing across development and commercial stages. Its Microbiological Testing Services include microbial limits testing, preservative efficacy testing, water testing and growth promotion studies. These services help confirm product safety, stability and contamination control, ensuring formulations meet pharmacopeial requirements such as USP and Ph. Eur. standards before release.
What role does sterility and contamination control play in Microbiological Testing Services at Cormica?
Sterility and contamination control are central to Cormica’s Microbiological Testing Services, particularly for injectables, biologics and high-risk medical devices. The company performs sterility testing, environmental monitoring and endotoxin analysis to detect microbial risks at early stages. This helps manufacturers maintain aseptic conditions throughout production and ensures compliance with strict regulatory expectations for sterile products.
How does Cormica ensure regulatory compliance in Microbiological Testing Services?
Cormica ensures compliance through globally accredited laboratories operating under GMP, GLP and ISO 17025 frameworks. Its Microbiological Testing Services are consistently aligned with USP, Ph. Eur., ISO and FDA requirements. Regular inspections and audits by regulatory authorities reinforce data integrity and testing reliability, enabling manufacturers to submit results with high regulatory confidence across international markets.
Why are Microbiological Testing Services important in modern pharmaceutical and medical device development?
Microbiological Testing Services are essential for ensuring that pharmaceutical products and medical devices are safe for patient use. Cormica applies these services to detect microbial contamination, validate sterilization processes and monitor production environments. As therapies become more complex, especially in biologics and combination products, robust microbiological testing helps reduce risk, maintain product quality and support regulatory approval pathways.
